Madrigal Pharmaceuticals, Inc.
MDGL
$421.90
$9.672.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.27% | -23.26% | 44.45% | 29.62% | -3.00% |
| Total Depreciation and Amortization | -0.69% | 19.83% | 21.81% | 11.61% | 58.93% |
| Total Amortization of Deferred Charges | -14.91% | -9.54% | 0.42% | 1.69% | -27.94% |
| Total Other Non-Cash Items | 24.70% | 18.03% | 1.69% | -28.54% | 22.62% |
| Change in Net Operating Assets | 15.43% | 41.15% | -392.48% | 368.10% | 63.67% |
| Cash from Operations | 47.07% | 14.93% | -55.99% | 50.36% | 9.53% |
| Capital Expenditure | -- | -- | 74.97% | -494.66% | 63.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -70.80% | 443.16% | 76.31% | -65.30% | -223.94% |
| Cash from Investing | -70.80% | 441.77% | 76.31% | -65.76% | -224.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.85% | -56.30% | 164.96% | -94.44% | -76.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -79.85% | -56.30% | 164.96% | -94.44% | -76.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.95% | 163.04% | 49.35% | -113.08% | -123.52% |